| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| VTVT | $13.20 | -3.93% | 2 | 30 | $34 | $10.80 | 22.2% |
vTv Therapeutics Inc.
3980 Premier Drive
Suite 310
High Point, NC 27265
United States
vTv is a clinical stage biotechnology company with a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients.